Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / pandemic - Page 79

pandemic

Pharnext and University Hospital Institute Mediterranee Infection announce effort to evaluate repurposed drugs for potential use against COVID-19 virus
Biotechnology | COVID-19 | Therapeutics

Pharnext and University Hospital Institute Mediterranee Infection announce effort to evaluate repurposed drugs for potential use against COVID-19 virus

On Apr. 21, 2020, Pharnext and the University Hospital Institute Mediterranee Infection in France, announced a new joint…

Read More Pharnext and University Hospital Institute Mediterranee Infection announce effort to evaluate repurposed drugs for potential use against COVID-19 virusContinue

Vaxart announced positive preclinical data for ioral COVID-19 vaccine program
COVID-19 | Life Science History | Vaccine

Vaxart announced positive preclinical data for ioral COVID-19 vaccine program

On Apr. 21, 2020, Vaxart announced it had obtained positive pre-clinical results for its COVID-19 vaccine candidates, with…

Read More Vaxart announced positive preclinical data for ioral COVID-19 vaccine programContinue

aTyr Pharma announced phase 2 study of ATYR1923 in COVID-19 patients with severe respiratory complications
COVID-19 | FDA | Life Science History

aTyr Pharma announced phase 2 study of ATYR1923 in COVID-19 patients with severe respiratory complications

On Apr. 21, 2020, aTyr Pharma announced the FDA has accepted its Investigational New Drug application to evaluate…

Read More aTyr Pharma announced phase 2 study of ATYR1923 in COVID-19 patients with severe respiratory complicationsContinue

ViralClear submited application for Vicromax through FDAs Coronavirus Treatment Acceleration Program for accelerated clinical trials
COVID-19 | FDA | Pharmaceutical | Therapeutics

ViralClear submited application for Vicromax through FDAs Coronavirus Treatment Acceleration Program for accelerated clinical trials

On Apr. 21, 2020, BioSig Technologies announced that subsidiary ViralClear Pharmaceuticals, had submitted an application for Vicromax(tm) (merimepodib,…

Read More ViralClear submited application for Vicromax through FDAs Coronavirus Treatment Acceleration Program for accelerated clinical trialsContinue

Tyson Fresh Meats resumed limited operations at Columbus Junction Pork Plant
COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine

Tyson Fresh Meats resumed limited operations at Columbus Junction Pork Plant

On Apr. 21, 2020, Tyson Fresh Meats resumed limited operations at its pork plant in Columbus Junction, Iowa,…

Read More Tyson Fresh Meats resumed limited operations at Columbus Junction Pork PlantContinue

OpGen subsidiary Curetis GmbH and Karolinska Institutet collaborated in study of bacterial Co-infections in COVID-19 pneumonia patients
COVID-19 | Life Science History

OpGen subsidiary Curetis GmbH and Karolinska Institutet collaborated in study of bacterial Co-infections in COVID-19 pneumonia patients

On Apr. 21, 2020, OpGen announced the start of an investigator initiated collaboration with Karolinska Institutet, Sweden, to…

Read More OpGen subsidiary Curetis GmbH and Karolinska Institutet collaborated in study of bacterial Co-infections in COVID-19 pneumonia patientsContinue

LabCorp COVID-19 at-home test kit received FDA Emergency Use Authorization
COVID-19 | FDA | Life Science History

LabCorp COVID-19 at-home test kit received FDA Emergency Use Authorization

On Apr. 21, 2020, LabCorpᆴ announced it has received an Emergency Use Authorization (EUA) from the FDA. The…

Read More LabCorp COVID-19 at-home test kit received FDA Emergency Use AuthorizationContinue

Quest Diagnostics began performing COVID-19 antibody testing
COVID-19 | Life Science History

Quest Diagnostics began performing COVID-19 antibody testing

On Apr. 21, 2020, Quest Diagnostics announced that it has begun to perform antibody testing for coronavirus (COVID-19)…

Read More Quest Diagnostics began performing COVID-19 antibody testingContinue

More than 800 employees from Rutgers, Robert Wood Johnson University Hospital and University Hospital participate in a pioneering study
Biotechnology | COVID-19 | Non-Profit Research | Therapeutics

More than 800 employees from Rutgers, Robert Wood Johnson University Hospital and University Hospital participate in a pioneering study

On Apr. 21, 2020, Rutgers University announced it has launched the nation’s largest prospective study of health care…

Read More More than 800 employees from Rutgers, Robert Wood Johnson University Hospital and University Hospital participate in a pioneering studyContinue

New virus detection process under development at Rutgers-Camden
COVID-19 | Life Science History

New virus detection process under development at Rutgers-Camden

On Apr. 21, 2020,the fight against the coronavirus is underway in a Rutgers UniversityヨCamden research laboratory, where chemistry…

Read More New virus detection process under development at Rutgers-CamdenContinue

Novartis announced plan to initiate clinical study of Jakavi in severe COVID-19 patients
Biotechnology | COVID-19 | FDA | Infectious Disease | Therapeutics

Novartis announced plan to initiate clinical study of Jakavi in severe COVID-19 patients

On Apr. 20, 2020, Novartis announced it had reached an agreement with the U.S. Food and Drug Administration…

Read More Novartis announced plan to initiate clinical study of Jakavi in severe COVID-19 patientsContinue

Anixa Biosciences and OntoChem announced collaboration to develop novel COVID-19 therapeutics
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

Anixa Biosciences and OntoChem announced collaboration to develop novel COVID-19 therapeutics

On Apr. 20, 2020, Anixa Biosciences announced it had entered into a strategic collaboration with OntoChem GmbH to…

Read More Anixa Biosciences and OntoChem announced collaboration to develop novel COVID-19 therapeuticsContinue

Alexion announced plans to initiate phase 3 study of ULTOMIRISᆴ (ravulizumab-cwvz) in hospitalized patients with severe COVID-19
COVID-19 | FDA | Life Science History

Alexion announced plans to initiate phase 3 study of ULTOMIRISᆴ (ravulizumab-cwvz) in hospitalized patients with severe COVID-19

On Apr. 20, 2020, Alexion announced plans to initiate a global Phase 3 study to investigate ULTOMIRISᆴ (ravulizumab-cwvz)…

Read More Alexion announced plans to initiate phase 3 study of ULTOMIRISᆴ (ravulizumab-cwvz) in hospitalized patients with severe COVID-19Continue

Screening of 11,552 compounds identified Innovation Pharma’s Brilacidin as promising Potential inhibitors of novel Coronavirus COVID-19
COVID-19 | FDA | Life Science History

Screening of 11,552 compounds identified Innovation Pharma’s Brilacidin as promising Potential inhibitors of novel Coronavirus COVID-19

On Apr. 20, 2020, Innovation Pharma reported that based on molecular screening of 11,552 compounds comprising already FDA-approved…

Read More Screening of 11,552 compounds identified Innovation Pharma’s Brilacidin as promising Potential inhibitors of novel Coronavirus COVID-19Continue

IDEXX made pet test for COVID-19 Virus available to veterinarians
Biotechnology | COVID-19 | Diagnostics | Therapeutics | Veterinary

IDEXX made pet test for COVID-19 Virus available to veterinarians

On Apr. 20, 2020, IDEXX Labs announced the availability of the IDEXX SARS-CoV-2 (COVID-19) RealPCR Test for pets….

Read More IDEXX made pet test for COVID-19 Virus available to veterinariansContinue

Rice University  COVID-19 research fund awarded first grants
Biotechnology | COVID-19 | Diagnostics | Therapeutics

Rice University COVID-19 research fund awarded first grants

On Apr. 20, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it will support…

Read More Rice University COVID-19 research fund awarded first grantsContinue

Atossa Therapeutics submitted Clinical Investigation approval to FDA for launch of COVID-19 HOPE study
COVID-19 | FDA | Life Science History

Atossa Therapeutics submitted Clinical Investigation approval to FDA for launch of COVID-19 HOPE study

On Apr. 20, 2020, Atossa Therapeutics announced that it had applied to the FDA for approval to commence…

Read More Atossa Therapeutics submitted Clinical Investigation approval to FDA for launch of COVID-19 HOPE studyContinue

Kaiser Permanente Washington announced Coronavirus vaccine trial to include older people
COVID-19 | Non-Profit Research | Vaccine

Kaiser Permanente Washington announced Coronavirus vaccine trial to include older people

On Apr. 17, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that older adults were being enrolled…

Read More Kaiser Permanente Washington announced Coronavirus vaccine trial to include older peopleContinue

Sinovac announced commencement of phase I human clinical trial for vaccine candidate against COVID-19
COVID-19 | Vaccine

Sinovac announced commencement of phase I human clinical trial for vaccine candidate against COVID-19

On Apr. 17, 2020, Sinovac Biotech announced that the Company had commenced Phase I clinical trial, a randomized,…

Read More Sinovac announced commencement of phase I human clinical trial for vaccine candidate against COVID-19Continue

FDA granted ExThera’s Seraph-100 blood filter Emergency Use Authorization for treatment of COVID-19 after promising results in europe and U.S.
COVID-19 | FDA | Medical Device | Therapeutics

FDA granted ExThera’s Seraph-100 blood filter Emergency Use Authorization for treatment of COVID-19 after promising results in europe and U.S.

On Apr. 17, 2020, after promising COVID-19 treatments in Germany, France, Italy, Spain and the U.S,, ExThera Medical’s…

Read More FDA granted ExThera’s Seraph-100 blood filter Emergency Use Authorization for treatment of COVID-19 after promising results in europe and U.S.Continue

Incyte announced initiation of phase 3 RUXCOVID study evaluating Ruxolitinib (Jakafi) as treatment for COVID-19 patients
Biotechnology | COVID-19 | Therapeutics

Incyte announced initiation of phase 3 RUXCOVID study evaluating Ruxolitinib (Jakafi) as treatment for COVID-19 patients

On Apr. 17, 2020, Incyte announced the initiation of RUXCOVID, a global, randomized, double-blind, placebo-controlled phase 3 clinical…

Read More Incyte announced initiation of phase 3 RUXCOVID study evaluating Ruxolitinib (Jakafi) as treatment for COVID-19 patientsContinue

Emory University Began enrolling older adults in COVID-19 vaccine clinical trial
COVID-19 | Life Science History | Vaccine

Emory University Began enrolling older adults in COVID-19 vaccine clinical trial

On Apr. 17, 2020, Emory University announced it had begun enrolling adults over age 55 in the clinical…

Read More Emory University Began enrolling older adults in COVID-19 vaccine clinical trialContinue

Slower clearance of Coronavirus infection may explain why men fare worse than women
Biotechnology | COVID-19 | Diagnostics | Non-Profit Research | Therapeutics

Slower clearance of Coronavirus infection may explain why men fare worse than women

On Apr. 17, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine may have solved…

Read More Slower clearance of Coronavirus infection may explain why men fare worse than womenContinue

The NIH launched a public-private partnership to speed COVID-19 vaccine and treatment options
CDC | COVID-19 | Life Science History | NIH

The NIH launched a public-private partnership to speed COVID-19 vaccine and treatment options

On Apr. 17, 2020, the NIH and the Foundation for the NIH are bringing together more than a…

Read More The NIH launched a public-private partnership to speed COVID-19 vaccine and treatment optionsContinue

Antiviral remdesivir prevented disease progression in monkeys with COVID-19
COVID-19 | NIH | Therapeutics

Antiviral remdesivir prevented disease progression in monkeys with COVID-19

On Apr. 17, 2020, the NIH announced that early treatment with the experimental antiviral drug remdesivir significantly reduced…

Read More Antiviral remdesivir prevented disease progression in monkeys with COVID-19Continue

Five Oxford University COVID-19 projects received UK Research and Innovation funding
COVID-19 | Non-Profit Research | Therapeutics | Vaccine

Five Oxford University COVID-19 projects received UK Research and Innovation funding

On Apr. 17, 2020, five projects from across Oxford University’s Medical Sciences Division were among twenty-one new studies…

Read More Five Oxford University COVID-19 projects received UK Research and Innovation fundingContinue

Roche developed new serology test to detect COVID-19 antibodies
Biotechnology | COVID-19 | Diagnostics

Roche developed new serology test to detect COVID-19 antibodies

On Apr. 17, 2020, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to…

Read More Roche developed new serology test to detect COVID-19 antibodiesContinue

IVI, INOVIO, and KNIH partner with CEPI in phase 1/2 clinical trial of INOVIO’s COVID-19 DNA vaccine in South Korea
COVID-19 | Infectious Disease | NIH | Vaccine

IVI, INOVIO, and KNIH partner with CEPI in phase 1/2 clinical trial of INOVIO’s COVID-19 DNA vaccine in South Korea

On Apr. 16, 2020, the International Vaccine Institute (IVI) announced that the Coalition for Epidemic Preparedness Innovations (CEPI)…

Read More IVI, INOVIO, and KNIH partner with CEPI in phase 1/2 clinical trial of INOVIO’s COVID-19 DNA vaccine in South KoreaContinue

Mammoth Biosciences announced peer-reviewed validation of its rapid, CRISPR-based COVID-19 diagnostic
Biotechnology | COVID-19 | CRISPR | Infectious Disease

Mammoth Biosciences announced peer-reviewed validation of its rapid, CRISPR-based COVID-19 diagnostic

On Apr. 16, 2020, Mammoth Biosciences announced the publication of a study demonstrating the power of its platform…

Read More Mammoth Biosciences announced peer-reviewed validation of its rapid, CRISPR-based COVID-19 diagnosticContinue

Dynavax and Sinovac announced collaboration to develop a Coronavirus (COVID-19) vaccine
COVID-19 | FDA | Life Science History

Dynavax and Sinovac announced collaboration to develop a Coronavirus (COVID-19) vaccine

On Apr. 16, 2020, Dynavax and Sinovac Biotech, a leading provider of biopharmaceutical products in China, announced a…

Read More Dynavax and Sinovac announced collaboration to develop a Coronavirus (COVID-19) vaccineContinue

Page navigation

Previous PagePrevious 1 … 77 78 79 80 81 … 98 Next PageNext
  • Categories
  • Timeline
  • Aesthetics
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemistry
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Banner Advertising

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search